 |
The Journal of Neuroscience, August 11, 2004, 24(32):7159-7166; doi:10.1523/JNEUROSCI.1027-04.2004
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Serotonergic Regulation of the Orexin/Hypocretin Neurons through the 5-HT1A Receptor
Yo Muraki,1 *
Akihiro Yamanaka,1,2,3 *
Natsuko Tsujino,1 *
Thomas S. Kilduff,3
Katsutoshi Goto,1 and
Takeshi Sakurai1,2
1Department of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan, 2Exploratory Research for Advanced Technology Yanagisawa Orphan Receptor Project, Japan Science and Technology Corporation, Tokyo 135-0064, Japan, and 3Molecular Neurobiology Laboratory, SRI International, Menlo Park, California 94025
Both orexin and serotonin (5-HT) have important roles in the regulation of sleep-wakefulness, as well as in feeding behavior. We examined the effects of 5-HT on orexin/hypocretin neurons, using hypothalamic slices prepared from orexin/enhanced green fluorescent protein (EGFP) transgenic mice in which EGFP is expressed exclusively in orexin neurons. Patch-clamp recording from EGFP-expressing cells showed that 5-HT hyperpolarized all orexin neurons in a concentration-dependent manner. The response was inhibited by the 5-HT1A receptor antagonist WAY100635. A 5-HT1A receptor agonist, 8-hydroxy-2-(dl-N-propyl-amino)tetralin, also evoked hyperpolarization on orexin neurons with potency comparable with 5-HT. A low concentration of Ba2+ (30 µM) inhibited 5-HT-induced hyperpolarization. Single-channel recording revealed that the conductance of 5-HT-induced channel activity was 33.8 pS, which is in good agreement with that of the G-protein-coupled inward rectifier potassium channel (GIRK). Moreover, 5-HT1A receptor-like immunoreactivity was observed on orexin neurons, and 5-HT transporter immunoreactive nerve endings are in close apposition to orexin neurons. Intracerebroventricular injection of the 5-HT1A receptor-selective antagonist WAY100635 (100 ng) increased locomotor activity during the latter half of dark phase in wild-type mice but not in orexin/ataxin-3 mice in which orexin neurons are specifically ablated, suggesting that activation of orexin neurons is necessary for the WAY100635-induced increase in locomotor activity. These results indicate that 5-HT hyperpolarizes orexin neurons through the 5-HT1A receptor and subsequent activation of the GIRK and that this inhibitory serotonergic input to the orexin neurons is likely to be important for the physiological regulation of this neuropeptide system.
Key words: orexin; hypocretin; serotonin; patch clamp; transgenic mouse; slice
Received March 20, 2004;
revised June 21, 2004;
accepted June 22, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Rao, M. Lu, F. Ge, D. J. Marsh, S. Qian, A. H. Wang, M. R. Picciotto, and X.-B. Gao
Regulation of Synaptic Efficacy in Hypocretin/Orexin-Containing Neurons by Melanin Concentrating Hormone in the Lateral Hypothalamus
J. Neurosci.,
September 10, 2008;
28(37):
9101 - 9110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Feng, D. Vurbic, Z. Wu, Y. Hu, and K. Strohl
Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine
J Psychopharmacol,
September 1, 2008;
22(7):
784 - 791.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Diniz Behn, N. Kopell, E. N. Brown, T. Mochizuki, and T. E. Scammell
Delayed Orexin Signaling Consolidates Wakefulness and Sleep: Physiology and Modeling
J Neurophysiol,
June 1, 2008;
99(6):
3090 - 3103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsunematsu, L.-Y. Fu, A. Yamanaka, K. Ichiki, A. Tanoue, T. Sakurai, and A. N. van den Pol
Vasopressin Increases Locomotion through a V1a Receptor in Orexin/Hypocretin Neurons: Implications for Water Homeostasis
J. Neurosci.,
January 2, 2008;
28(1):
228 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gillette
Evolution and Function in Serotonergic Systems
Integr. Comp. Biol.,
December 1, 2006;
46(6):
838 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xie, T. L. Crowder, A. Yamanaka, Stephen. R. Morairty, R. D. LeWinter, T. Sakurai, and T. S. Kilduff
GABAB receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus
J. Physiol.,
July 15, 2006;
574(2):
399 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yamanaka, Y. Muraki, K. Ichiki, N. Tsujino, T. S. Kilduff, K. Goto, and T. Sakurai
Orexin Neurons Are Directly and Indirectly Regulated by Catecholamines in a Complex Manner
J Neurophysiol,
July 1, 2006;
96(1):
284 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault, K.-P. Lesch, M. Hamon, and J. Adrien
Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter.
J. Neurosci.,
May 17, 2006;
26(20):
5554 - 5564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tsujino, A. Yamanaka, K. Ichiki, Y. Muraki, T. S. Kilduff, K.-i. Yagami, S. Takahashi, K. Goto, and T. Sakurai
Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor
J. Neurosci.,
August 10, 2005;
25(32):
7459 - 7469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Winsky-Sommerer, A. Yamanaka, S. Diano, E. Borok, A. J. Roberts, T. Sakurai, T. S. Kilduff, T. L. Horvath, and L. de Lecea
Interaction between the Corticotropin-Releasing Factor System and Hypocretins (Orexins): A Novel Circuit Mediating Stress Response
J. Neurosci.,
December 15, 2004;
24(50):
11439 - 11448.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|